A white "Biointelect" logo is displayed against a dark green/black background.
Search
Contact Us
BRINGING INNOVATIONS TO LIFE STEP BY STEP

Integrated full-service Contract Research Organisation (CRO) and Consulting Expertise Driving Life Sciences Innovation

Biointelect is a globally recognised Australian consulting and advisory firm offering a unique blend of full-service Contract Research Organisation (CRO) capabilities and commercialisation consulting. With deep roots in the full health innovation ecosystem, Biointelect provides end-to-end support across the entire development pathway from early-stage research through to market access and health system integration.

Speak with Our Experts

Our Services

R&D Strategy & Planning →

Clinical Affairs Services →

Director Services →

Regulatory Strategy →

Commercialisation Strategy →

Patient Access & Health Economics →

Government Services & Public Policy →

Our Proven Track Record

Clients
0 +
Projects
0 +
Countries
0

Our Clients

Strategic Partnerships

CR2O provide leadership and operational excellence in conducting Phase I-IV clinical trials and their global network of experts.

Centre for Biopharmaceutical Excellence Logo

CBE provide technical support as the experts in facility design, manufacturing, quality and good manufacturing practice (GMP) accreditation.

QNova LifeSciences Logo

QNova Life Sciences provide direct FDA support through their US-based consultancy.

5 Horizons Ventures is a US‑based VCaaS firm that combines structured capital with CRO execution partners to help biotechs overcome early‑stage funding and delivery barriers to reach clinical validation.

 

Memberships

Bio NSW Logo
Logo of BioMelbourne Network with text Progressing BioIndustry

Latest News

Follow Us on LinkedIn

Get in Touch

Wherever you are in your new product journey, Biointelect’s unique expertise across each stage of the life science value chain means we are ready to bring your innovative life science to market.

Take the next steps in advancing healthcare for all by contacting our team of local Australian and global life science experts today.

Speak with Our Experts

Secure your innovation’s long-term commercial viability as a successful resource that supports healthcare professionals and patients in need.


  • Our team of public policy analysts and health economists offer leadership in market shaping.
  • Leverage our innovative thinking in health and life sciences infrastructure, including the design of public-private partnerships and strategic planning for major projects.
  • Establish category thought leadership with our White Paper development and publishing.
  • Optimise return on investment with robust pricing strategy and comprehensive life cycle management.
  • Deep industry expertise makes us an ideal go-to partner for non-industry partners seeking engagements.

New Product Planning | Policy Shaping | White Papers | Lifecycle Management

Navigate the challenges of bringing a therapy to market leveraging our broad cross-functional experience. Build vital knowledge to inform all stages of market readiness.


  • Work with our functional experts to develop a commercial strategy that optimises market positioning and maximises impact and value.
  • Achieve your regulatory goals; our global network and deep expertise in regulatory pathways inspires our tailored solutions across strategic planning, implementation, and direct engagement with regulatory agencies to ensure compliance and accelerate market entry.
  • Capitalise on our diverse leadership experience in HTA to strategically prepare your submission.
  • Undertake financial and economic modelling with data analysis to support corporate and product commercialisation strategy.

Regulatory Submissions | HTA Assessment | Economic Assessment | Commercialisation Strategy

Lay the essential foundations for commercial success by drawing on our knowledge of the life science ecosystem, regulatory and clinical pathways.


  • Understand your potential with our comprehensive market analysis services and take the first steps towards commercialisation with our business insights.
  • Prepare the pathway forward with a regulatory roadmap and robust clinical development strategies.
  • Generate a strategic trial design, and conduct the trials to ensure robust clinical outcomes that reflect the full potential of your asset.
  • Establish a local presence to capitalise on research and development incentives with our Director Services to register an Australian corporate entity and appoint an ASIC-approved, Australian resident company director to oversee local clinical development initiatives.

Market Analysis and Business Insights | Director Services | Clinical Development Strategy |
Clinical Trial Execution | Full Service CRO Services | Regulatory Strategy

Leverage our expertise and strategic project management to refine your innovative ideas into actionable and successful commercial projects.


  • Collaborate with our team to prioritise and develop a clear, compelling value proposition that sets your innovation apart in the market.
  • Create a strong business case and funding proposals that secure the resources needed to drive your project forward.
  • Benefit from our Strategic Project Management services to streamline the entire product development process and optimise your path to market.
 

Research & Development Strategy and Planning | Grant Funding and Business Case Proposals | Portfolio Prioritisation | Target Product Profile Development

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.